Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies-Reference-Cited by-同舟云学术

Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies

Published:2020-02-01 Issue:1 Volume:33 Page:34-42
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Haughie Scott¹,Allan Richard¹,Wood Nolan²,Ward Jon¹

Affiliation:

1. Mylan Pharma UK Ltd., Sandwich, United Kingdom.

2. Certara UK Ltd., London, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2019.1537

Reference16 articles.

1. Salmeterol/Fluticasone Propionate

2. Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) Compared with Fluticasone Propionate (Fp) Mdpi and FS DPI in Subjects with Persistent Asthma

3. World Medical Association Declaration of Helsinki

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Bioequivalence between Generic and Originator Orally Inhaled Drug Products: Validity of Administration of Doses above the Approved Single Maximum Dose;Molecular Pharmaceutics;2024-08-12

2. Mechanistic modeling of generic orally inhaled drug products: A workshop summary report;CPT: Pharmacometrics & Systems Pharmacology;2022-12-20

3. Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function;Evidence-Based Complementary and Alternative Medicine;2022-08-11

4. In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2021-11-02

5. The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device;Pulmonary Medicine;2021-03-17